Saved Activities


0 Activities
0 Activities
No image set

Challenges to CGM Adoption and Use


Activity Info

The overall goal of IDEA (Innovating Decisions and Empowering Action in Diabetes Management) is to improve understanding of continuous glucose monitoring, report interpretations, and the use of this information to optimize therapeutic management leading to practice transformation and increased shared decision-making

CME Information


Activity Title

Challenges to Continuous Glucose Monitoring (CGM) Adoption and Use



Accreditation Type

AMA PRA Category 1 Credit(s)™/ANCC-Nursing/CDR-Dieticians/ABIM MOC Part 2

Release Date

November 30, 2020

Expiration Date

November 29, 2022

Estimated Time to Complete Activity

30 minutes


Upon completion of the activity, participants should be able to:

  • Identify current guidelines for utilization of CGM in the care of patients with diabetes
  • Compare and contrast current CGM guideline recommendations
  • Anticipate common questions from patients and clinicians related to CGM
  • Discuss current and emerging advances in the use of CGM


Grazia Aleppo, MD
Richard M. Bergenstal, MD
Lawrence Blonde, MD, FACP, MACE
Jenna Brothers, PA-C
Amy Butts, PA-C, CDE, BC-ADM
Shelly Enders, PharmD
Gregory Forlenza, MD
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDE
Rodolfo Galindo, MD
Davida Kruger, MSN
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE
Carol Levy, MD
Jodi Lavin-Tompkins, APRN
Joshua Neumiller, PharmD
Gina McClure
Stuart Perry
Anne Peters, MD
Gregg Simonson, PhD
Madhuri Mukhopadhyay Vasudevan, MD


  1. There are no fees for participating in and receiving credit for this activity
  2. Review the activity objectives and CME/CE information
  3. Complete the cases you are interested in; each case is its own CME/CE activity.
  4. When you have finished completing your chosen cases, complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs
    • If you are requesting educational credits or a certificate of participation—your CME/CE certificate will be available for download.
    • If you are requesting ABIM MOC points, your MOC points will be submitted electronically to the ACCME, which will register data and notify certifying boards.


This activity is provided by the American College of Endocrinology in collaboration with The France Foundation.

This education is intended for endocrine specialists including endocrinologists, advanced practice professionals (dietitians, nurse practitioners and physician assistants), nurse and diabetes care and education specialists, and primary care providers (MDs, PAs, nurses) who care for patients with diabetes.

The overarching goal of this initiative is to improve understanding of glucose monitoring, report interpretations, and the use of this information to optimize therapeutic management, leading to practice transformation and increased shared decision-making. The planned educational and awareness programs can help participants implement systemic health system changes to improve overall patient outcomes.

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

American Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this activity for a maximum of 0.5 ANCC contact hours.

The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 0.5 contact hours. RNs must retain this document for 4 years after the activity concludes.

RNs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR): CDR Credentialed Practitioners will receive up to 0.5 Continuing Professional Education units (CPEUs) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Certified Diabetes Care and Education Specialists: To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.ncbde.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

The following planners, reviewers, editors, staff, and CME committee who control content have relevant financial relationships to disclose:

  • Dr. Aleppo has received research support from Dexcom, Eli Lilly, and Insulet. She has received honoraria from Dexcom and Insulet.
  • Dr. Bergenstal has received research support, consulted, or has been on a scientific advisory board for Abbott Diabetes Care, Ascensia, DexCom, Hygieia, Johnson & Johnson, Lilly, Medtronic, Novo Nordisk, Onduo, Roche, Sanofi, and United Healthcare.
  • Dr. Blonde has received honoraria from AstraZeneca, Gilead Sciences, Janssen, Merck and Co, and Novo Nordisk. He has also served as a speaker for Janssen and Novo Nordisk. He has served as a consultant and received research support from Novo Nordisk and Sanofi.
  • Ms. Brothers has nothing to disclose.
  • Ms. Butts has served on the speakers bureau for Janssen, NovoNordisk, and Zeris. She has also served on the advisory board for Novo Nordisk.
  • Dr. Enders spouse has received salary from Sanofi-Genzyme. Dr. Forlenza has received research support from Abbott, Beta Bionics, Dexcom, Medtronic, and Tandem Diabetes. He has served as a consultant for Beta Bionics, Lilly, and Medtronic. He has also served on the speakers bureau for Dexcom, Insulet, and Tandem Diabetes.
  • Ms. Hess-Fischl has received honoraria from Abbott and Xeris.
  • Dr. Galindo has received research support from Novo Nordisk and has served as a consultant for Sanofi, Eli Lilly, Novo Nordisk, and Valeritas.
  • Ms. Kruger has served on advisory boards for Abbott, Boehringer Ingelheim Pharmaceuticals, Inc, Dexcom, Eli Lilly, Janssen, Merck, Novo Nordisk, Pendulum, and Sanofi Aventis. She has also participated on the speakers bureau for Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc, Dexcom, Eli Lilly, Insulet, Janssen, Novo Nordisk, Valeritas, and Xeris. She has received research support from Abbott, Dexcom, Hemsley Foundation, Lexicon, and Novo Nordisk.
  • Dr. Isaacs has received honoraria from Abbott, Companion Medical, and Dexcom.
  • Dr. Levy has received research support from Abbott and Dexcom and has received honoraria from Dexcom.
  • Ms. Lavin-Tompkins has nothing to disclose.
  • Dr. Neumiller has received honoraria from the American Diabetes Association.
  • Ms. McClure has nothing to disclose.
  • Mr. Perry has served as a consultant for Novo Nordisk.
  • Dr. Peters has participated in advisory boards for Abbott Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc, Eli Lilly and Company, Livongo, MannKind, Merck, Novo Nordisk, Sanofi, and Pendulum Therapeutics. She has received research support from Dexcom and vTvTherapeutics. She has also participated in the speakers bureau for Novo Nordisk.
  • Dr. Simonson has served on the advisory board for Merck & Co, Inc, and has received grant funding from Abbott Diabetes Care.
  • Dr. Vasudevan has nothing to disclose.

The following planners, reviewers, editors, staff, and CME committee who control content have no relevant financial relationships to disclose.

The American College of Endocrinology (AACE)

  • Brian Block, LMS and Technology Manager
  • Elizabeth Lepkowski, MATD, Chief Learning Officer
  • Michelle McNeilly, MHA, Director of Online Education and Technology

American College of Clinical Pharmacy (ACCP)

  • Erika Michalski, MEd

American Academy of Physician Assistants (AAPA)

  • Eric Peterson, EdM, FACEHP, CHCP

American Society of Endocrine Physician Assistants (ASEPA)

  • Wendy McLaughlin, PA-C

Diabetes Patient Advocacy Coalition (DPAC)

  • Julie Babbage
  • Mike Swearingen

T1D Exchange

  • Daniel Pereira
  • Wendy Wolf

The diaTribe Foundation

  • Kelly Close
  • Frida Velcani

The France Foundation

  • Carrie Burton, MPA
  • Heather Tarbox, MPH
  • Eve Wilson, PhD

This activity is supported by educational grants from Abbott Diabetes Care, AstraZeneca, Eli Lilly, Medtronic, and Novo Nordisk Inc.

The American College of Endocrinology presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American College of Endocrinology and the commercial supporter(s) assume no liability for the information herein.

Copyright © 2020 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy-policy.

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.



Webinar | Primary Care | MOC | CME (AMA PRA Category 1 Credit) | 0.50 - 30 mins | Nurse | Nurse Practitioner | Diabetes |